De novo development of small cyclic peptides that are orally bioavailable.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- De novo development of small cyclic peptides that are orally bioavailable.
- Published In:
- Nature chemical biology, 20(5), 624-633 (2024)
- Authors:
- Merz, Manuel L, Habeshian, Sevan, Li, Bo(5), David, Jean-Alexandre G L, Nielsen, Alexander L, Ji, Xinjian, Il Khwildy, Khaled, Duany Benitez, Maury M, Phothirath, Phoukham, Heinis, Christian
- Database ID:
- RPEP-08868
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08868APA
Merz, Manuel L; Habeshian, Sevan; Li, Bo; David, Jean-Alexandre G L; Nielsen, Alexander L; Ji, Xinjian; Il Khwildy, Khaled; Duany Benitez, Maury M; Phothirath, Phoukham; Heinis, Christian. (2024). De novo development of small cyclic peptides that are orally bioavailable.. Nature chemical biology, 20(5), 624-633. https://doi.org/10.1038/s41589-023-01496-y
MLA
Merz, Manuel L, et al. "De novo development of small cyclic peptides that are orally bioavailable.." Nature chemical biology, 2024. https://doi.org/10.1038/s41589-023-01496-y
RethinkPeptides
RethinkPeptides Research Database. "De novo development of small cyclic peptides that are orally..." RPEP-08868. Retrieved from https://rethinkpeptides.com/research/merz-2024-de-novo-development-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.